AFT Pharmaceuticals

Auckland, New Zealand Founded: 1997 • Age: 29 yrs
Proprietary and in-licensed pharmaceutical products are developed and distributed.
Request Access

About AFT Pharmaceuticals

AFT Pharmaceuticals is a company based in Auckland (New Zealand) founded in 1997.. The company has 119 employees as of March 31, 2024. AFT Pharmaceuticals has completed 3 acquisitions, including Angelini Pharma, Expanscience and Therabel. AFT Pharmaceuticals offers products and services including Maxigesic and Generic Drugs.

  • Headquarter Auckland, New Zealand
  • Employees 119 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aft Pharmaceuticals Ltd.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $116.62 M (USD)
    6.45
    as on Mar 31, 2024
  • Net Profit
    $6.7 M (USD)
    -23.36
    as on Mar 31, 2024
  • EBITDA
    $10.97 M (USD)
    -23.93
    as on Mar 31, 2024
  • Latest Funding Round
    $48.24 M (USD), Post-IPO

    Jun 11, 2020

  • Investors
    CRG

    & 1 more

  • Employee Count
    119

    as on Mar 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of AFT Pharmaceuticals

AFT Pharmaceuticals is a publicly listed company on the NZX with ticker symbol AFT in New Zealand, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NZX · Ticker: AFT . Sector: Health technology · New Zealand

Products & Services of AFT Pharmaceuticals

AFT Pharmaceuticals offers a comprehensive portfolio of products and services, including Maxigesic and Generic Drugs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Maxigesic is developed as a combination analgesic that is distributed through licensing agreements for pain management purposes.

Generic drugs are offered as part of a portfolio that includes in-licensed and patented options for various health needs.

People of AFT Pharmaceuticals
Headcount 50-200
Employee Profiles 16
Board Members and Advisors 4
Employee Profiles
People
Scott Crawford
General Manager - Promoted Products
People
Ioana Stanescu
Head of Drug Development
People
Hartley Atkinson
Director
People
Vladimir Ilievski
Regulatory Affairs Manager

Unlock access to complete

Board Members and Advisors
people
David Flacks
Chairman
people
Doug Wilson
Independent Director
people
Jon Lamb
Independent Director
people
Ted Witek
Independent Non-Executive Director

Unlock access to complete

Funding Insights of AFT Pharmaceuticals

  • Total Funding
  • Total Rounds 4
  • Last Round Post-IPO — $48.2M
  • First Round

    (01 May 2014)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2020 Amount Post-IPO - AFT Pharmaceuticals Valuation

investors

Mar, 2017 Amount Post-IPO - AFT Pharmaceuticals Valuation

investors

CRG
May, 2014 Amount Debt – Conventional - AFT Pharmaceuticals Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AFT Pharmaceuticals

AFT Pharmaceuticals has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include CRG and Milford Asset Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
CRG is recognized as a premier healthcare investment partner.
Founded Year Domain Location
Milford Asset Management is engaged in investment and wealth management.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AFT Pharmaceuticals

AFT Pharmaceuticals has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Angelini Pharma, Expanscience and Therabel. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Dermo-cosmetic products, pharmaceutical drugs, and cosmetic active ingredients are developed.
1950
Pharmaceutical products are provided through industry partnerships for distribution.
1945
Manufacturer and developer of active ingredients, branded drugs, medical products and dietary supplements
1919
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - AFT Pharmaceuticals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aft Pharmaceuticals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AFT Pharmaceuticals

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aft Pharmaceuticals

Frequently Asked Questions about AFT Pharmaceuticals

When was AFT Pharmaceuticals founded?

AFT Pharmaceuticals was founded in 1997 and raised its 1st funding round 17 years after it was founded.

Where is AFT Pharmaceuticals located?

AFT Pharmaceuticals is headquartered in Auckland, New Zealand.

How many employees does AFT Pharmaceuticals have?

As of Mar 31, 2024, the latest employee count at AFT Pharmaceuticals is 119.

What is the annual revenue of AFT Pharmaceuticals?

Annual revenue of AFT Pharmaceuticals is $116.62M as on Mar 31, 2024.

What does AFT Pharmaceuticals do?

Founded in 1997 and based in Auckland, New Zealand, operations in the pharmaceutical sector are conducted. Proprietary and in-licensed products, including patented, branded, and generic drugs, are developed and distributed. Research and development efforts are directed toward innovative solutions for unmet healthcare needs, with analgesics and eye care items featured in the portfolio. Out-licensing agreements are utilized for international distribution.

What products or services does AFT Pharmaceuticals offer?

AFT Pharmaceuticals offers Maxigesic and Generic Drugs.

Is AFT Pharmaceuticals publicly traded?

Yes, AFT Pharmaceuticals is publicly traded on NZX under the ticker symbol AFT.

How many acquisitions has AFT Pharmaceuticals made?

AFT Pharmaceuticals has made 3 acquisitions, including Angelini Pharma, Expanscience, and Therabel.

Who are AFT Pharmaceuticals's investors?

AFT Pharmaceuticals has 2 investors. Key investors include CRG, and Milford Asset Management.

What is AFT Pharmaceuticals's ticker symbol?

The ticker symbol of AFT Pharmaceuticals is AFT on NZX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available